FIELD: medicine.
SUBSTANCE: claimed group of inventions relates to the field of medicine. Claimed are a method and a set for determination of the presence in a patient of a higher risk of possessing cardiovascular disease or disorder by polymorphic variants of genes. Claimed is a method of identifying the patient, requiring early and/or aggressive or preventive therapy of cardiovascular disease and a method of treating such patient.
EFFECT: claimed group of inventions provides effective methods and sets for determining a risk of possessing cardiovascular disease, which makes it possible to identify the patient requiring therapy of cardiovascular disease.
10 cl, 4 dwg, 18 tbl, 1 ex
| Title | Year | Author | Number |
|---|---|---|---|
| RISK MARKERS FOR CARDIOVASCULAR DISEASES IN PATIENTS WITH CHRONIC KIDNEY DISEASE | 2014 |
|
RU2656148C2 |
| GENETIC MARKERS FOR PREDICTION OF SUSCEPTIBILITY TO THERAPY | 2014 |
|
RU2707533C2 |
| GENETIC POLYMORPHISMS ACCOMPANYING AGE-RELATED MACULAR DEGENERATION | 2010 |
|
RU2546008C2 |
| GENETIC POLYMORPHISMS IN AGE-RELATED MACULAR DEGENERATION | 2010 |
|
RU2577726C2 |
| GENETIC MARKERS FOR PREDICTING SENSITIVITY TO THERAPY | 2014 |
|
RU2809215C2 |
| GENETIC MARKERS FOR PREDICTING RESPONSE TO THERAPY BY RAISING HDL LEVEL OR IMITATING HDL AGENTS | 2015 |
|
RU2703192C2 |
| THROMBOEMBOLIC DISEASE MARKERS | 2012 |
|
RU2606758C2 |
| METHOD OF FINDING PRONENESS TO HIGH-ALTITUDE PULMONARY EDEMA | 2003 |
|
RU2353656C2 |
| METHOD OF GENOTYPING TLR2 GENE USING RS5743708 POLYMORPHISM AND A SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR ITS IMPLEMENTATION | 2023 |
|
RU2805861C1 |
| METHOD OF GENOTYPING TLR8 GENE USING RS3764880 POLYMORPHISM AND A SET OF OLIGONUCLEOTIDE PRIMERS AND PROBES FOR ITS IMPLEMENTATION | 2023 |
|
RU2805864C1 |
